Esteban Nogales‐Fernández

Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial

Carlos Jiménez‐Cortegana, Natalia Palazón‐Carrión, Alejandro Martı́n et al. · Journal for ImmunoTherapy of Cancer · 2021 · 62 citations · Full text

Life Sciences, Hematology, Immunology +17

Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer

Natalia Palazón‐Carrión, Carlos Jiménez‐Cortegana, María Luisa Sánchez-León et al. · Scientific Reports · 2021 · 36 citations · Full text

Medicine, Immunology, Oncology +17

Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice

Elísabeth Pérez-Ruiz, Jerónimo Jiménez-Castro, Miguel‐Ángel Berciano‐Guerrero et al. · Clinical & Translational Oncology · 2020 · 19 citations

Life Sciences, Immunology, Oncology +16

Circulating regulatory T cells from breast cancer patients in response to neoadjuvant chemotherapy

Víctor Sánchez‐Margalet, Antonio Barco-Sánchez, Teresa Vilariño‐García et al. · Translational Cancer Research · 2019 · 19 citations · Full text

Life Sciences, Immunology, Oncology +17

Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis

Natalia Palazón‐Carrión, Alejandro Martı́n, Esteban Nogales‐Fernández et al. · Clinical Cancer Research · 2022 · 15 citations · Full text

Medicine, Oncology, Pharmacotherapy +16